Quick Search
Comparison of Screening And Treatment Protocols Of Sexually Transmitted Diseases
Savaş KanburGedik Istanbul University Faculty of Health Sciences, Occupational Health and Safety Department, Istanbul, TurkeyINTRODUCTION: Vulvovaginal complaints are one of the top reasons for applying to medical institutions in women. Vulvovaginal infections also take an important place in chief complaints in sexually transmitted diseases in women. Sexually transmitted diseases can cause permanent reproductive health problems in women. This situation shows the importance of the fact that sexually transmitted diseases must be diagnosed in patient population who apply to medical institutions with vulvovaginal infection symptoms. Today bacterial, parasitic and fungal vulvovaginal infection causes like Candida Albicans, Gardnerella Vaginalis, Trichomonas Vaginalis, N. Gonorrhoeae, Syphilis
make up 80% of the total vulvovaginal diseases. In this cross-sectional study, having information on the frequency of sexually transmitted diseases in Turkey indirectly and comparison of treatment options are aimed.
METHODS: 386 non-bleeding patients who applied to Doktor Zekai Tahir Burak Women’s Hospital gynecology polyclinic, were screened for STD (Sexually Transmitted Disease). Culture, fresh preparate, and gram staining methods were used for screening. In any of these methods, individuals from groups where agent was not shown, who had leucocyte count greater than 10, were identified as leucocyte group. In the screening, individuals from groups where agent was not shown, who had leucocyte count less than 10, were identified as local hygiene group. Group which was identified as leucocyte was considered as the 20% that was not in the scope of this study, consist of viral and idiopathic agents.
RESULTS: Between April-June 1996, 386 patients who were eligible for given conditions, applied to Gynaecology polyclinic.
Candida 19.9% (77 patients), Trichomonas 2.3% (9 patients), and Bacteriel Vaginosis as the second most frequent with 15%
were observed. Patient count with leucocyte were found as 11.3% (30 patients) and this group was considered as Chlamydia
+ Microplasma + Viral infection. 268 patients underwent examinations, and this was accounted as 69.4% of the total group. Effectiveness of treatment differences were compared.
DISCUSSION AND CONCLUSION: In our study, gonorrhea 1.03% (4/386), syphilis 1.03% (4/386), trichomonas 2.3% (9/386), Bacterial Vaginosis 15.2% (59/386), Candida Albicans 19.9% (77/386) were found in non-bleeding patients who applied to Gynaecology Polyclinic. We decided that, even though treatment protocols have different active agents, treatment agents don’t have superiority over one another, no matter how precisely treatment protocols were applied, as the changes caused by individual behavior differences cannot be eliminated.
Manuscript Language: English
